These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21886515)

  • 1. Health technology assessment and private payers' coverage of personalized medicine.
    Trosman JR; Van Bebber SL; Phillips KA
    J Oncol Pract; 2011 May; 7(3 Suppl):18s-24s. PubMed ID: 21886515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment and private payers's coverage of personalized medicine.
    Trosman JR; Van Bebber SL; Phillips KA
    Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP53-60. PubMed ID: 21711078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value and consequences of using public health technology assessments for private payer decision-making in Canada: one size does not fit all.
    Pericleous L; Amin M; Goeree R
    J Med Econ; 2019 May; 22(5):478-487. PubMed ID: 30757934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.
    Trosman JR; Van Bebber SL; Phillips KA
    J Oncol Pract; 2010 Sep; 6(5):238-42. PubMed ID: 21197187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples.
    Brogan AP; DeMuro C; Barrett AM; D'Alessio D; Bal V; Hogue SL
    J Manag Care Spec Pharm; 2017 Feb; 23(2):125-134. PubMed ID: 28125369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.
    Trosman JR; Weldon CB; Douglas MP; Deverka PA; Watkins JB; Phillips KA
    Value Health; 2017 Jan; 20(1):40-46. PubMed ID: 28212967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping US commercial payers' coverage policies for medical interventions.
    Chambers JD; Chenoweth MD; Neumann PJ
    Am J Manag Care; 2016 Sep; 22(9):e323-8. PubMed ID: 27662396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value added medicines: what value repurposed medicines might bring to society?
    Toumi M; Rémuzat C
    J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy.
    Denburg AE; Giacomini M; Ungar W; Abelson J
    Int J Health Policy Manag; 2022 Mar; 11(3):374-382. PubMed ID: 32801223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
    Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
    Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report.
    Drummond MF; Augustovski F; Bhattacharyya D; Campbell J; Chaiyakanapruk N; Chen Y; Galindo-Suarez RM; Guerino J; Mejía A; Mujoomdar M; Ollendorf D; Ronquest N; Torbica A; Tsiao E; Watkins J; Yeung K;
    Value Health; 2022 Aug; 25(8):1257-1267. PubMed ID: 35931428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders.
    Facey KM; Rannanheimo P; Batchelor L; Borchardt M; de Cock J
    Int J Technol Assess Health Care; 2020 Sep; ():1-10. PubMed ID: 32878663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessment of biosimilars worldwide: a scoping review.
    Ascef BO; Lopes ACF; de Soárez PC
    Health Res Policy Syst; 2020 Aug; 18(1):95. PubMed ID: 32843051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan.
    Almomani E; Alabbadi I; Fasseeh A; Al-Qutob R; Al-Sharu E; Hayek N; Tarawneh MR; Kaló Z
    Value Health Reg Issues; 2021 Sep; 25():126-134. PubMed ID: 34015521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment in Australia: a role for clinical registries?
    Scott AM
    Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capacity building for assessing new technologies: approaches to examining personalized medicine in practice.
    Van Bebber SL; Trosman JR; Liang SY; Wang G; Marshall DA; Knight S; Phillips KA
    Per Med; 2010 Jul; 7(4):427-439. PubMed ID: 21857867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.